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Abstract: There has been considerable recent interest in employing computer models to investigate
the relationship between the structure of a molecule and its dermal penetration. Molecular
permeation across the epidermis has previously been demonstrated to be determined by a number of
physicochemical properties, for example, the lipophilicity, molecular weight and hydrogen bonding
ability of the permeant. However little attention has been paid to modeling the combined effects
of permeant properties in tandem with the properties of vehicles used to deliver those permeants
or to whether data obtained using synthetic membranes can be correlated with those obtained
using human epidermis. This work uses Principal Components Analysis (PCA) to demonstrate that,
for studies of the diffusion of three model permeants (caffeine, methyl paraben and butyl paraben)
through synthetic membranes, it is the properties of the oily vehicle in which they are applied
that dominated the rates of permeation and flux. Simple robust and predictive descriptor-based
quantitative structure–permeability relationship (QSPR) models have been developed to support
these findings by utilizing physicochemical descriptors of the oily vehicles to quantify the differences
in flux and permeation of the model compounds. Interestingly, PCA showed that, for the flux of
co-applied model permeants through human epidermis, the permeation of the model permeants
was better described by a balance between the physicochemical properties of the vehicle and the
permeant rather than being dominated solely by the vehicle properties as in the case of synthetic
model membranes. The important influence of permeant solubility in the vehicle along with the
solvent uptake on overall permeant diffusion into the membrane was substantiated. These results
confirm that care must be taken in interpreting permeation data when synthetic membranes are
employed as surrogates for human epidermis; they also demonstrate the importance of considering
not only the permeant properties but also those of both vehicle and membrane when arriving at any
conclusions relating to permeation data.
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1. Introduction
The in vitro and in vivo experimental measurement of skin permeability is a difficult and complex
process, due in part to ethical concerns regarding human and animal experimentation. As a consequence,
there has been a great interest in recent years to avoid unnecessary, time consuming and costly in vitro
testing by developing models that would allow formulation scientists to predict the ability of a
compound to cross the skin based on its physicochemical characteristics.
One approach used to identify this relationship between molecular properties and skin
permeation is multivariate analysis. A number of attempts have been made to develop quantitative
structure–permeability relationship (QSPR) models of skin permeability by seeking linear correlations
between observed experimental values for permeation and the physicochemical properties and/or
molecular structure parameters of the chemical compounds being studied (see, e.g., [1–9]). Such models
have been used by environmental agencies for the safety assessment of dermal exposure to industrial
and environmental hazards, and also by pharmaceutical companies to screen and select drugs for
possible transdermal delivery potential.
Permeability through the skin is thought to be controlled by the physicochemical properties of both
the permeant and the vehicles used to deliver it. For example, the chemical structure of a vehicle can
determine the effect that it is likely to have on membranes and/or on the partitioning of the penetrant,
leading to the observed changes in the skin penetration profile. However, most previous predictive
models of permeability have largely concentrated on the chemical structure of the permeant and
have not considered the effect of either vehicle or membrane on the diffusion process (see e.g., [2,10]).
Many of the developed QSPR models are based on a database assembled by Flynn [1]. It is comprised
from 97 human skin permeability coefficients for 94 compounds obtained in vitro through human
skin from 15 different literature sources. Nevertheless, previous experiments have demonstrated
that the vehicle and the membrane are as important as the permeant, since they are able to enhance
or retard the permeation by virtue of their physical and chemical properties [11]. Different studies
have showed that vehicles penetrate into the membranes and skin, affecting it through different
mechanisms; these involve disruption of the intercellular lipids of the highly ordered stratum corneum
(SC), interaction with intracellular proteins, or improvement of the drug partition into the stratum SC,
including lipid fluidization, disruption of lipid structure, lipid extraction and also irreversible protein
denaturation in SC [12,13].
Applications of Principal Components Analysis (PCA) have found widespread use in most
stages of pharmaceutical research and industry. For example, it has been used in distinguishing,
quantifying and predicting the compression behavior of pure excipients and binary blends on tablet
formation and properties [14], and formulation scientists have used such analysis for characterizing
the performance of nebulizers [15]. In addition, PCA has been used to study the relative importance
of certain structural characteristics in terms of their contribution to transdermal permeation [9];
and classification of drugs according to their mode of action [16]. The application of multivariate
analysis to experimental data obtained for a number of different penetrants, in a range of vehicles
across synthetic membranes and epidermis, could provide an important insight into possible means of
enhancing dermal delivery, leading to the development of new therapeutic formulations. Therefore,
there is an interest in the construction of prediction models for skin permeability since most existing
models are based on linear algorithms, although nonlinear models applying nonlinear regression
techniques, including artificial neural networks or support vector regression and random forest,
have also been developed and applied to QSPR models [17–20]. Several authors have worked on
different mathematical computer-generated penetration models to predict the release, flux, or skin
permeability of different topical formulations [21–23]. However, for the development of robust and
predictive QSPR models, it is important that all experimental data be consistent and reliable. Ideally,
all experiments should be performed under standardized conditions, such as employing the same
skin type from the same anatomical region and maintaining constant laboratory conditions such as
temperature, permeant concentration and receptor medium. Practically, this has not been the case;
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therefore, a potential limitation of existing QSPR models of skin permeation is that the data used
to build and validate them are derived from an extensive database from different investigators and
laboratories using disparate experimental protocols, which could undermine the generalizability of
a model.
Hence, the aim of this study was to use multivariate analyses on a self-consistent set of experiments
to better understand the influence of physicochemical properties of permeants, oily vehicles and
membranes on: solvent uptake by membranes (i.e., a vehicle–membrane interaction) and the flux and
permeability coefficient of the compounds moving through those membranes.
2. Materials and Methods
2.1. Materials
Methanol, acetonitrile and hexadecane (HD) were obtained from Merck chemicals, Darmstadt,
Germany; orthophosphoric acid from Riedel-de-Haen Chemical, Seelze, Germany; potassium hydroxide
from Scharlau Chemical, Barcelona, Spain; methyl paraben (MP), butyl paraben (BP), caffeine (CF)
and triethylamine from Sigma Chemical Co., Gillingham, UK; oleic acid (OA) and liquid paraffin
(LP) from Sigma, Taufkirchen, Germany; isopropanol from BDH Laboratory Supplies, Poole, UK;
isopropylmyristate (IPM) and isohexadecane (IHD) from Uniqema, Klang, Malaysia; and silicone
membrane from Samco Ltd., Nuneaton, UK. Whatman no. 1 filter paper was purchased from Whatman
International Ltd, Maidstone, UK. High-density polyethylene (HDPE) membrane (pharmaceutical
grade package material) and polyurethane (PU) membrane were donated by TQ pharma, Amman,
Jordan and Exopack, Wrexham, UK, respectively.
2.2. HPLC Chromatographic Conditions for Model Permeants
A Class VP 2010 LC Pump with Auto sampler connected to a UV Absorbance Detector were
employed (Shimadzu, Kyoto, Japan). The column used for all permeants was a Symmetry 5 µm BDS
(C18), 150 × 4.6 mm (5 µm) (Waters, Milford, MA., USA). The mobile phase for MP consisted of 35%
acetonitrile/65% v/v phosphate buffer (50 mM KH2PO4 containing 1% w/v triethylamine, then adjusted
to pH 3.5 with orthophosphoric acid). The mobile phase for the assay of BP was 50% acetonitrile/50%
phosphate buffer (50 mM KH2PO4 adjusted to pH 3.0 with orthophosphoric acid) and for CF was 15%
acetonitrile/85% v/v phosphate buffer (50 mM KH2PO4 adjusted to pH 3.0 with orthophosphoric acid).
The flow rate was maintained at 1 mL min−1 and injection volumes were 10 µL for MP and BP and
50 µL for CF. The wavelength of detection (nm) was 254, 256 and 270 for MP, BP and CF respectively
(n ≥ 4).
2.3. Franz Cells Studies-Synthetic Membranes.
The protocol for the Franz cell experiments using synthetic membranes are described in detail
elsewhere [24].
2.4. Franz Cell Studies Human Epidermis
Fresh, surgically excised samples of human skin were obtained directly after abdomino-plastic
surgery carried out on a 35-year-old Middle Eastern female patient attending a private clinic in
Amman, Jordan, with informed consent. The board of directors and the ethics committee of Dawoud
Clinic (Amman 11182, Jordan) reviewed and approved the informed consent (TDRE-001 approved on
01/02/2011). Subcutaneous fat was carefully removed from the skin sample using forceps and a scalpel.
Following the removal of the fat, individual portions of skin were immersed in water at 60 ◦C for 45 s.
The skin was then pinned, dermis side down, on a corkboard, and the epidermis (comprising stratum
corneum and epidermal layer) was gently removed by rolling the membrane using forceps. The dermis
was then discarded, and the epidermal membrane floated onto the surface of water and was taken up
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onto a Whatman no.1 filter paper. The resultant epidermal sheets were blotted dry with tissue paper,
wrapped in aluminium foil and stored flat at −70 ◦C until use, and checked for integrity before use.
In order to determine the extent to which permeant bound to the filter paper, circular pieces of
filter paper were immersed in 5 mL of a standard solution (10 µg mL−1) of each permeant in phosphate
buffer. Samples (200 µL) were removed from each vial after 0.5, 4, 6 and 8 h and assayed using HPLC.
The permeation of MP, BP and CF from either the oily vehicles or orthophosphate buffer (pH 7.0)
was determined as follows. The receptor compartment of a Franz cell was carefully filled with
phosphate buffer, the temperature of which was maintained at 32 ◦C. A small Teflon-coated magnetic
bar (around 5 mm) was included in the receptor compartment such that stirring was maintained
throughout the duration of the experiment. String rate and temperature were fixed during the entire
course of the experiment. The epidermal membrane was then allowed to equilibrate with the receptor
fluid for 1 h, after which 200 µL of the oily suspension was introduced onto the stratum corneum
(i.e., donor compartment). The duration of each skin permeation experiment was 8 h for MP and BP
and 10 h for CF. The permeant concentration of receptor samples was analysed by HPLC (n ≥ 4).
The concentration of the permeant in the receptor solution at any time point was corrected for
previous sample removal. The cumulative amount of permeant crossing the epidermis per unit of
skin surface area was plotted as a function of time, and the slope of the linear portion of the plot was
determined and taken as a measure of the average flux (J, µg cm−2 h−1).
2.5. Data Pre-Treatment and Statistical Analyses
Permeation data reported in this study are mean values (n ≥ 4) with accompanying standard
deviation (sd). In order to establish differences in the parameters measured, statistical analysis of the
data was undertaken using either analysis of variance (ANOVA) or Student’s t-test, as appropriate.
Post hoc comparisons of the means of individual groups after carrying out ANOVA were performed
using Tukey’s test. ANOVA and Post hoc Tukey’s test were performed using SYSTAT version 5.0
(SYSTAT Software Inc., San Jose, CA, USA), and the level of significance for results was taken at p ≤ 0.05
in all cases.
2.6. Principal Component Analysis
Molecular descriptors for the penetrants, vehicles and membranes used in the PCA were
calculated using Molecular Operating Environment 2012, (Chemical Computing Group Inc., Montreal,
QC, Canada), and Hansen solubility parameters (HSP) by the HSPiP software (version 4.0.0.4,
www.hansen-solubility.com). All abbreviations are defined in Appendix I. These included δD,
δP, δH, solubility parameter MPa
1
2 , HSP distance (Equation (1)) between the oils and membranes;
Mvol, Mwt, density, Mpoint, Log Ko/w, ovality, molecular connectivity index, weight, Log P, TPSA,
vdw_vol, vdw_area, a_nH, a_nC, a_nO, b_1rotN, b_1rotR, b_count, b_double, b_rotN, b_rotR, b_single,
lip_acc, lip_don, opr_brigid, opr_nrot, chi0, chi0_C, chi1, chi1_C, chi0v, chi0v_C, Kier1, Kier2, Kier3,
Kier flex, balabanJ, Q_VSA_HYD_PEOE_VSA_HYD, b_ar, opr_nring, Q_VSA_POL_PEOE_VSA_POL,
Q_VSA_FHYD_PEOE_VSA_FHYD, Q_VSA_FPOL_PEOE_ and VSA_FPOL. The HSP distance between
the oils and membranes was calculated using Equation (1):
Distance2 = 4(δDA− δDB)2 + (δPA− δPB)2 + (δHA− δHB)2, (1)
where A and B are oils and membranes, respectively.
PCA of the descriptors was carried out using Unscrambler X (CAMO software, Oslo, Norway)
for four experiments: solvent uptake, flux and Kp, for synthetic membranes and flux alone through
epidermis. Identification of important descriptors for individual experiments was achieved in an
iterative manner as follows. PCA loadings plots for each of the experiments were analyzed and the
descriptor that had the lowest absolute value on PC-1 in the plot was removed. The rationale for this
is that such a descriptor does not contribute to the explanation of the experimental variance in the
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PCA model. The PCA model was then regenerated using the remaining input variables. This process
was repeated until only the descriptors relevant to explaining the variance in the dataset remained. If,
upon removal of a variable, there was a decrease in the percentage of explained variance seen in PC-1,
or a loss of orthogonality between the principal components (PCs), then the descriptor was returned to
the model and the process terminated, as the minimal number of variables required to explain the
variance in the dataset had been identified.
2.7. Generation and Evaluation of QSPR Models
QSPR models to predict flux and permeation coefficients across synthetic membranes were
generated and evaluated using the QuaSar module in the molecular operating environment (MOE)
software. To this end, the initial dataset (36 observations, corresponding to 36 combinations of
permeant/vehicle/membrane) was divided into training (30 observations) and test sets (6 observations),
ensuring that the test set was representative of the range of membranes, oily vehicles and permeants
investigated. The data analytical workflow is presented graphically in Figure 1.
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A cross-correlation matrix for all of the descriptors given in Section 2.6 was generated. If two
descriptors demonstrated absolute correlation coefficient values above 70% with one another,
the descriptor least correlated with the dependent variable (either flux or permeation coefficient) was
removed from the analysis. This was carried out to guard against the over-representation of related
molecular properties in the final models. The remaining descriptors were then subjected to zero mean
unit variance scaling.
QSPR models were constructed using the estimate linear model (ELM) equation and the Estimated
Normalized Linear Model (ENLM) algorithms in the QuaSAR module in MOE. A correlation coefficient
(r2 value) and the cross-validated correlation coefficient (q2 value) were generated and used as measures
of model quality and robustness, respectively. Iterative refinement of initial models was achieved by
removing the molecular descriptor in the equation identified as contributing least to the initial model
and regenerating the QSPR equation. This process was carried out until the r2 and q2 values were
in close proximity, and the model possessed the highest r2 values possible with the least number of
molecular descriptors. The r2 values obtained from the test set was then used to assess the predictive
quality of the refined models (Figure 1).
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3. Results
3.1. Effect of Vehicle on Diffusion through Human Epidermis
The amount of drug binding to the filter paper on which the epidermis was supported during the
Franz cell study was found to be negligible for all three penetrants (data not shown). The parameters
derived from the in vitro epidermal diffusion studies are shown in Table 1. The fluxes and permeability
coefficients of model permeants penetrating the skin when the compounds were applied in IHD as a vehicle
were found to be significantly higher (p ≤ 0.05) than those which diffused from any other vehicles. IHD is
small in size and has high flexibility compared to other oils. The mean flux values were in the order of
MP > BP > CF. Nevertheless, all oils significantly enhanced the diffusion of model permeants through the
human epidermis compared with phosphate buffer (ANOVA and Tukey’s test; p < 0.05).
Table 1. In vitro epidermal permeation parameters, permeability coefficients (KP) and fluxes (Js) for
methyl paraben (MP), butyl paraben (BP) and caffeine (CF) from different oily vehicles and phosphate
buffer pH 7.0. Data represent mean ± sd (n = 4 or 5).
Vehicle
Js (µg cm−2 h−1) KP (10−2 cm h−1)
CF MP BP CF MP BP
Buffer 4.22 ± 0.69 26.28 ± 0.42 17.60 ± 0.57 0.02 ± 0.002 1.09 ± 0.02 7.04 ± 0.22
IHD 36.60 ± 1.41 115.6 ± 10.54 86.02 ± 3.80 49.47 ± 1.90 152.61 ± 13.9 11.03 ± 0.49
IPM 14.56 ± 1.11 67.82 ± 2.49 56.11 ± 2.27 1.75 ± 0.13 0.19 ± 0.007 0.06 ± 0.002
OA 11.23 ± 0.53 56.27 ± 1.06 54.05 ± 1.49 0.21 ± 0.010 0.86 ± 0.02 0.09 ± 0.002
HD 9.43 ± 0.53 47.78 ± 2.51 44.61 ± 4.61 12.74± 0.71 60.47 ± 3.17 5.95 ± 0.61
LP 9.66 ± 0.46 43.24 ± 2.94 26.98 ± 1.20 12.54 ± 0.60 61.77 ± 4.19 3.70 ± 0.16
3.2. Principal Component Analysis
Hotelling’s test [25,26] showed that there were no outliers in the dataset. The data obtained using
liquid paraffin (LP) as a vehicle were not included in these analyses, as this vehicle is comprised of a
mixture of disparate molecular components (of poorly defined composition) and is therefore difficult
to accurately characterize using the available molecular descriptors [27]. Molecular descriptors for the
penetrants, vehicles and membrane is essential to explaining the variation in the measurements in each
of the four experiments, as determined by PCA, are summarized in Table 2.
Table 2. Physicochemical descriptors, categorized according to whether they are related to the vehicle,
permeant or membrane, that were identified by Principal Components Analysis (PCA) as important for
explaining the variation in experimental observation for the solvent uptake, flux through membranes,
and permeability coefficient through synthetic membranes and flux through epidermis.
Experiment Physicochemical DescriptorsRelating to the Vehicle
Physicochemical Descriptors
Relating to the Permeant
Physicochemical Descriptors




molecular connectivity index (vehicle);
opr_brigid (vehicle);
chi0_C (vehicle).




lip_don (vehicle); chi1_C (vehicle).
solubility of the permeants in the oils;
δP (permeant).
weight ratio of treated:
untreated membranes;
Hansen Solubility Parameter






molecular connectivity index (vehicle);
opr_brigid (vehicle);
chi0 (vehicle).
solubility of the permeants in the oils;
Mpoint (permeant).
weight ratio of treated:
untreated membranes;
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3.3. PCA Analyses: Synthetic Membranes
3.3.1. Solvent Uptake
An examination of the model for solvent uptake shows that the first two PCs in this experiment
describe 77% of the total variance in the data (Figure 2). The molecular descriptors δDm and δTm
were removed from the analysis because the initial results showed them to be so different to the other
descriptors that they skewed the analysis. This was not surprising, since only a limited number of
membranes (three) with vastly different solubility parameters were under study. However, despite
δDm and δTm not loading heavily on either PC1 or PC2, these were the only parameters in the initial
descriptor set that represented the properties of the membrane. If this study is to be robust, membrane
descriptors should not be excluded, and so an alternative was needed. To this end, the distance
between the Hansen Solubility Parameter (HSP) values of the membranes and vehicles, was introduced.
This derived parameter represents a measure of the degree of matching (i.e., similarity) between the
solubility parameters of the vehicles and the membranes [28]. The lower the HSP distance value,
the more alike the polymer (membrane) and solvent (oily vehicle). Therefore, the vehicle that has
similar partial components to the partial components of the membrane might be expected to induce
the greatest swelling of the membrane, consequently modifying the partitioning and diffusion of
permeants through the membrane. Therefore, HSP distance represents a descriptor relating the vehicle
to the membrane (i.e., a vehicle–membrane interaction term). HSP distance was shown by PCA to be
significant in its contribution to explaining the variance of the data with respect to solvent uptake.
The scores plot (Figure 2A) shows that there was no significant clustering of data with respect to
the membrane used, i.e., each membrane investigated was found in all of the different groups on the
plot. In contrast, the clustering was clearly correlated with the oily vehicle used. Hence, these findings
suggest that variation in the extent of solvent uptake in synthetic membranes is dominated by the
properties of the vehicle used to deliver the penetrant. This is supported by analysis of the associated
loadings plot (Figure 2B), which shows that the majority of the descriptors that have high loading
values on PC1 and PC2 are describing the properties of the oily vehicle.
The scores plot (Figure 2A) shows the four oily vehicles cluster into three distinct groups. IPM and
OA, both of which contain heteroatoms which render them more polar than IHD and HD, are closely
grouped together in the upper right-hand quadrant of the plot. IHD and HD, which are simple
hydrocarbons, occupied their own distinct regions in the scores plot. The separation of HD and IHD
into two groups may appear initially surprising, given that HD is the linear counterpart of IHD. In fact,
the separation into two groups implies that the combination of descriptors which make up PC1 and
PC2 are identifying differences in the vehicles based on both electronic and steric properties. This is
supported by an examination of the loadings plots which, for example, show that the high loading
of chi0_C, (a topological descriptor encoding the size, shape and flexibility), on both PC1 and PC2 is
important for explaining the variance observed in the experimental results. This suggests that there is
a correlation between the size, flexibility and the ability to disrupt and swell the membrane, which was
also confirmed by the flux results of permeants from different oils through the membranes.
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Figure 2. (A) Scores plot from the PCA of solvent uptake of oily vehicles into synthetic membranes
showing clear groupings with respect to different vehicles (isohexadecane (IHD) in red, hexadecane
(HD) in orange, oleic acid (OA) in green and isopropylmyristate (IPM) in blue). The first two principal
components (PCs) explain 77% of the total variance in the dataset; 46% and 31% of the variability
are explained by PC1 and PC2, respectively. (B) Loading plots from the PCA of the solvent uptake
of oily vehicles into synthetic membranes showing descriptors, primarily related to describing the
physicochemical pro erties of the vehicle, being highly load d on PCs 1 and 2 and hence being most
responsible for explaining the variation in solvent uptake observed.
3.3.2. PCA Analyses of Flux and Permeation Coefficient (KP) in Synthetic Membranes
PCA experiments incorporating the molecular descriptors identified as being important for
explaining the variance in flux and permeation across synthetic membranes (Table 2) were carried
out. The data in the scores plot for flux (Figure 3A) are distributed into four groups, again clustered
according to the vehicle used, with the identity of the membrane and permeant seemingly less
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important for explaining the variance in the dataset. The loading plot for flux (Figure 3B) shows that
the H-bond acceptor of the vehicle has the greatest impact of the included descriptors in describing the
variance of the dataset. Chi1_C, a steric descriptor relating to localized branching within a molecule,
is also highly loaded indicating the importance of the overall topology of the oil in describing variation
in the dataset. The log Ko/w vehicle and solubility of the permeants in the oils are the descriptors
which are most highly loaded on PC2. These distributions of variables on both PCs indicate that the
flexibility and ease of interaction between the oil and membrane has a key role in the permeation
through membrane in addition to the solubility of the permeant in the oil. This suggests that the flux is
driven by the match between the oil where the drug should be soluble in the modified membrane.
On the other hand, if the drug solubility is low, the solvent might permeate into the skin leaving the
drug on the surface. The Kp score plot (Figure 3C) shows that the data are clustered into three groups.
One group consists of the experiments carried out using IPM and OA, the second contains the HD data
and the third the IHD data. In the Kp loading plot (Figure 3D), the molecular connectivity index for
the vehicle, a steric descriptor, was shown to have had the biggest effect in explaining the variance of
the data captured by PC1. Chi0 (vehicle), another steric descriptor, also contributes significantly to
explaining the variance captured by PC1. This descriptor is mainly related to the shape and bonding of
the vehicle indicating the importance of vehicle shape and flexibility in the permeation and disruption
of the membrane. PC2 showed high loadings for Log Ko/w (vehicle), a lipophilic descriptor. IPM and
OA have similar values for their molecular connectivity indices and Chi0 descriptors, and so their
proximity on the scores plot in this PCA is not surprising.
Hence, the parameters describing variance in flux and Kp in the dataset are lipophilic and steric
in nature. Once again, the loading plots are dominated by descriptors relating to the properties of the
oily vehicle. This indicates the impact of the vehicle in the flux process and is evidence to support the
initial concerns regarding the limitations of existing models of flux that only take the identity of the
permeant into account. Therefore, it can be assumed that the flexibility and size of the vehicle will
aid in its permeation through the membrane provided that there is a match of lipophilicity between
the membrane and vehicle. This was confirmed by the results of membrane swelling data with IHD,
which has the smallest and most flexible structure compared to other vehicles, since it was highly
sorbed to/into the membrane and enhanced the flux of model permeants. In contrast, oleic acid,
which has the largest molecular structure and is the least flexible, led to less swelling of the membrane
and less permeation of the permeants.
3.3.3. PCA Analysis of Flux through Epidermis
A PCA was carried out on the permeant and vehicle molecular descriptors for the flux of the
model compounds through human epidermis (Table 2, Figure 4). The first two PCs describe 59% of the
variance in the data. The scores plot shows that, unlike the synthetic membrane flux data, there is no
tight clustering according the identity of the vehicle. There is a pattern of separation that appears to be
due to both the identity of the permeant and the vehicle, although the flux of BP from IPM skews this
distribution. This phenomenon might be a consequence of the comparatively high solubility of BP in
IPM (120.8 ± 2.6 mg mL−1) relative to the solubility of BP in the other oily vehicles.
Upon examination of the loadings plot, the density of the vehicle, the solubility of the permeant
in the oil and opr-brigid, a steric descriptor capturing the relative rigidity of the vehicle resistance to
rotate along the vehicle molecular bond which will affect the flexibility of the movement, were found to
have the greatest loadings on PC1 with Chi0_C and chi0 values of the permeant being heavily loaded
on PC2. In contrast to the studies on synthetic membranes, this showed the importance of both the
identity of the permeant and the identity of the vehicle in determining flux in the epidermis studies.
The flux of the model permeants (MP > BP > CF) from the buffer across human epidermis reflected the
differences in lipophilicity of each of the permeants and the ease of the compounds in traversing the
skin barrier.
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Figure 3. (A) Scores plot from the PCA of flux and (C) scores plot from the PCA of permeation
coefficient through synthetic membranes showing clear groupings with respect to the different vehicles
used (IHD in red, HD in orange, OA in green and IPM in blue). (B) Loading plots from the PCA of flux
and (D) loading plots from the PCA of permeation coefficient across synthetic membranes showing
high loadings for descriptors primarily related to the physicochemical properties of the vehicle and the
solubility of the permeants in the vehicle contributing most to explaining the variance observed in
the datasets.
All oily vehicles enhanced the permeation of the model permeants from the saturated solutions
through the human epidermis relative to the buffer. The factors affecting the diffusion of permeants
from these vehicles may include differences in either (i) vehicle–skin effects and/or (ii) permeant–vehicle
affinity. Using a cellulose acetate nitrate membrane (non-rate limiting), the highest permeation was
attained using IHD. IHD is highly branched molecule which is more flexible than other vehicles
(Kier, 1989). Such results support the information provided by the loadings plot that the shape and
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Figure 4. (A) Score plot from PCA showing the relationship between permeant and oily vehicle
descriptors with epidermis flux. The two displayed PCs explain 33% and 26% of the variance,
respectively. (B) Loading plots from PCA showing the relationship betw en permeant-oily vehicle
descriptors with epidermis flux.
The distribution of variables on both PCs indicate that for flux to be achieved the oils should be
small and flexible so as to gain access to the membrane, disrupt the packing and modify it. The solubility
of the permeant in the solvent and the uptake of the solvent into the membrane were found to have
an influence on the flux. The permeant should have a high solubility in the oil that has entered the
membrane for the permeant to partition into the membrane. The permeant also should have high
solubility and diffusivity in the vehicle–membrane phase to drive permeation across the membrane.
The results of the solvent uptake and diffusion studies indicated that solvents which were taken up to
a significant extent into the membrane caused the membrane to swell and led to higher diffusion of the
permeant through the membrane.
3.4. Quantitative Structure-Property Relationship Models:
The initial three-descriptor ENLM QSPR (Estimated Normalized Linear Model Quantitative
Structure Property Relationship) model generated to account for the permeation coefficient (Kp)
through synthetic membranes had the form:
Kp = 0.41902 solubility− 0.85524 lip_acc vehicle + 0.64106 δHexp drug + 0.6976, (2)
where solubility represents the solubility of the permeant in the oily vehicle, lip_acc vehicle is the number
acceptors, as defined by Lipinski’s rules, for the oily vehicle and δHexp drug is a Hansen solubility
parameter that describes the energy due to hydrogen bonding of the permeant molecules.
The three-descriptor model gave an r2 value of 0.67 and a q2 value of 0.59 for the training set and
produced an r2 value of 0.56 for the test set. These values suggest that the model is relatively predictive,
and reasonably robust given the small differences between r2 and q2 values. This is encouraging given
the relatively small dataset. In addition, the fact that the training set q2 value is lower than the r2
value, and the r2 value of the test set is lower than that for the training set indicates the model is not
overfitted, i.e., it is reasonable to assume that it is a generally applicable model.
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The ENLM QSPR model generated to predict normalized flux (i.e., flux corrected for the thickness
of the synthetic membrane) gave the following six-descriptor equation:
Flux = 1.08083 + 0.23534 ×weight ratio − 0.36141 × log Ko/w vehicle − 0.24036 ×MPtpermeant −
1.01839 × δHexp membrane + 0.47908 × δPexp membrane − 0.34680 × normalized opr_brigidvehicle
(3)
where δHexp membrane and δPexp membrane are Hansen solubility parameters related to the energy due to
hydrogen bonding and dipolar interactions in the membrane, respectively, log Ko/w vehicle relates to the
octanol-water partition coefficient of the oily vehicle, weight ratio refers to the weight of the swollen
synthetic membrane in comparison to the original membrane weight, MPtpermeant is the melting point
of the permeant and opr_brigidvehicle describes the number of rigid bonds in the oily vehicle, as defined
by Oprea. This model reported a training set r2 of 0.72 and q2 of 0.59. The test set r2 value was 0.65,
again indicating a relatively robust, predictive and generalizable model.
No attempt was made to build QSPR models for predicting flux through epidermis because of the
small dataset (n = 9).
4. Discussion
4.1. Principal Component Analyses
The PCA results clearly demonstrate that the choice of vehicle (and hence the physicochemical
properties of the vehicle) is the most important factor in accounting for the differences observed in
permeation coefficients and flux across synthetic membranes. This was apparent from the clusters that
form within the scores plot which are grouped according to the oily vehicles used in the experiment and
the fact that the loadings plots show that the descriptors that are most heavily loaded, i.e., those that
are most important in explaining the observed variance in the dataset, are related to the properties of
the vehicle, such as size and flexibility, along with the physicochemical matching between the vehicle
and the membrane.
This dominance of properties of the oily vehicle was not evident when examining the experiments
which determined fluxes through human epidermis. In this instance, the experiments carried out
indicate that the properties of both the permeant and the oily vehicle play a part in determining the rate
of penetration of the compound. This stark difference between the behavior of synthetic membranes in
relation to oily vehicles and the behavior of excised skin in relation to the same substances is of interest
as it confirms the limitations of employing synthetic membranes as a surrogate for human excised skin
models. It has been previously concluded that membranes fail to provide an analogous model for the
complexity of the stratum corneum [29]. Nevertheless, several studies on different membranes have
been conducted trying to mimic the behavior of the skin. Carbosil membrane which is composed of
polydimethylsiloxane–polycarbonate block copolymer was shown to provide mechanistically based
models of a good predictive capacity for percutaneous drug transport [30,31]. Like human skin
epidermis, it has a heterophase and heteropolar structure; therefore, it was able to mimic the skin
permeation barrier where the drug transport process is described by a solubility (partition)-diffusion
process. The barrier function of the skin and carbosil was examined for a wide range of structures
and therapeutic classes of the drugs where their permeability coefficients had a clear dependence of
permeant properties alone (i.e., molecular weight, melting point, solubility in aqueous solution and
octanol–water partition coefficient) [30,32].
Drug permeation through epidermis has been identified previously as possibly being dependent
upon both the physicochemical properties of the drug and those of the vehicle comprising the
formulation. In the case of the epidermis, the vehicle can interact with the membrane to change the
phase behavior leading to fluidization of the intercellular lipids within the stratum corneum [12].
Other vehicles induce destabilization of the stratum corneum structure, and hence render it more
susceptible to penetration by concomitantly applied permeants [33]. The use of vehicles that are
sorbed by the membrane or interact with components of the membrane might induce changes
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in the physicochemical properties of the synthetic barriers due to the solvation of the polymer
chains. Silicone membrane is cross-linked in structure, and it is likely that the weight gain observed
following equilibration with specific oil is more associated with chain solvation and subsequent
membrane swelling interactions rather than polymer dissolution which can occur with non-cross-linked
barriers. Additionally, penetration-enhancing chemical agents are often co-formulated in vehicles,
which serve to improve the permeability of the epidermal barrier to xenobiotics. The understanding
of vehicle–membrane interactions is therefore a critical step not only in the selection of an optimal
penetration enhancer but also a prime factor affecting formulation design. Investigation of a possible
membrane–vehicle interaction, using solvent uptake, and then seeking to correlate this with the effect
on drug permeation, has been employed by a number of previous workers, although almost exclusively
employing aqueous- and alcoholic-based vehicles [34]. In the current study, it has been demonstrated
that PCA provides an effective analytical tool to examine multiple interacting vehicle, drug and barrier
descriptors to predict the influence of formulation on permeant flux across barrier membranes.
4.2. QSPR Models
A limitation of most of the previously generated models is that they only consider the permeant
descriptors and ignore the effect of the physicochemical properties of the vehicle or the membrane
under study on the permeant diffusion process [2,5,10,35]. Such a restriction may impact upon the
ability to develop representative models based on in vitro experimental data, since interactions between
the vehicle and the membrane may also alter the permeation process.
There is a good correlation between Kp and selected descriptors with r2 = 0.67 for the training set,
which is identical to the correlation in the established Potts and Guy [2] model [2]. Comparatively,
a better correlation was found between the flux and the descriptors with r2 of 0.72. Interrogation of
Equation (2) reveals the solubility of the permeant in the oil has a positive correlation with the flux,
and that those compounds that are more soluble in the oily vehicle have higher flux values. This is not
surprising given the fact that the descriptors relating to the oily vehicle are the ones that dominate in
the PCA plots, and this indicates that the interaction between the oil and the permeant, rather than the
permeant and the membrane is one of the most important factors for determining permeation across a
synthetic membrane, with this range of compounds and oily vehicles. This is not unexpected since the
permeant must have sufficient solubility in order to diffuse through the membranes, and particularly
so in the case of a vehicle-modified membrane. Previous studies have shown the importance of the
drug solubility in the vehicles which are sorbed by the membrane [13,36].
The importance of the vehicle is also evident when examining the second descriptor in the equation,
i.e., lip_acc (vehicle). This term will act to decrease the permeation coefficient of those vehicles that
have greater than zero heteroatoms (O or N). That is to say, increasing the number of hydrogen
bond acceptors in the vehicle decreases the flux through the membranes. In the membranes used in
our modeling, silicone and polyurethane membranes are both capable of interaction and hydrogen
bonding with the vehicles, which supports findings of a modification in the flux. The importance of the
hydrogen bond of the drug has been reported previously in human skin and silicone [37]. The present
study confirms the importance of H-bonding for the drug; however, unlike previous studies, it has
been shown here that the H-bonding behavior of the vehicle is also a determinant of permeant flux
across a barrier membrane. The molecular weight of the solvent also has an important effect on the
uptake and mobility of the solvent inside the membrane. It has long been known that the Log Ko/w
of the vehicle is an important descriptor for describing the solvent uptake and Kp [2,5]. However,
it has been demonstrated that an increase in alcohol sorption by silicone membranes with a carbon
number from ethanol to butanol (four carbon atoms) was observed, after which sorption decreased
exponentially with increasing aliphatic chain length [13]. Additionally, it has been demonstrated that
the sorption of vehicles into a membrane affects both the thermodynamic and kinetic components of
co-administered compound permeation [38].
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The solubility parameter of the vehicle is also an important predictor of the flux through the
membrane. Previous studies have shown that if the solubility parameter of the vehicle is close to
the solubility parameter of the skin, permeation may be enhanced [39]. Similarly, permeants with
a solubility parameter close to that of the skin will have a higher permeation rate through the skin.
The relationship between Kp of a series of alkanoic acids through porcine skin and solubility parameter
was reported to take the form of a parabola with a maximum permeability near a solubility parameter
of 20.46 (MPa)1/2 [40]. From the current study, the appearance of δHexp drug parameter in Equation (2)
demonstrates the importance of H-bonding contribution to the drug solubility parameter, whereby
a higher value favored permeation of the drug across the model membranes. This is in agreement
with findings of Cronin et al. [40] in their QSPR model for maximum steady state flux through silicone
membrane. The current work has identified that matching H-bonding properties of the permeant
with a vehicle component may provide a strategy to enhance molecular permeation into membranes.
A molecule having a hydrogen bonding ability may have a conformational flexibility, due to its
potential for intra- and inter-molecular interactions. When the membrane has become solvated by the
vehicle, H-bonding compatibility between the solvent and permeant might enhance the permeation of
the latter [41].
An examination of Equation (3), which describes the flux through the membrane shows six
descriptors in total were important to describe the flux across synthetic membranes. Descriptors
relating to the membrane, vehicle and permeant are incorporated—but the descriptors relating to the
membrane are of greatest importance in explaining flux, followed by those describing the vehicle
and then the permeant. The descriptors were in the order of δHexp membrane >> δPexp membrane > log
Ko/w vehicle > normalized opr_brigid vehicle > weight ratio > MPtpermeant. As indicated by the equation,
the most important factor (more than twice as dominant in its impact on flux as the next ranking
descriptor) is δHexp membrane. Therefore, the greater the hydrogen bonding ability of the membrane,
the bigger the effect on flux from the tested range of vehicles. This is in line with the Equation (2) results
confirming that if both the vehicle and membrane are capable of the hydrogen bonding, this may
increase the vehicle–membrane interaction. The resultant modification of the barrier properties
of the membrane may facilitate the flux enhancement of permeants that are soluble in the vehicle.
Furthermore, the equation shows that an increase in the polar component of the solubility parameter
of the membrane (δPexp membrane) leads to an increased flux and, conversely, that the lipophilicity of
the vehicle is inversely correlated with the flux. This may be due to less chances of interaction between
a polar membrane and a lipophilic vehicle.
The vehicles used in this study are all hydrophobic oils; therefore, increasing the lipophilicity of the
vehicle could lead to a decrease in partition of hydrophobic drug from the oil (or oil modified membrane
phase) and subsequent permeation. Equation (3) also confirms the importance of vehicle flexibility
(observed in the PCA results), where there is a negative correlation between the number of rigid bonds
in the vehicle and flux of the permeant across the membrane. This indicates that the less flexible the
vehicle is, the lower the chances of vehicle permeation and interaction with the membrane. Moreover,
the equation shows the importance of solvent uptake on the flux; the higher the vehicle uptake by
a given membrane, the higher the flux of a permeant. This finding was supported by the diffusion
results where a correlation was found between the amount of vehicle sorbed and the flux. The melting
point of the permeant was also negatively correlated with flux. The melting point is a physicochemical
property which has also been considered as a determinant of the solubility of the permeant in both the
vehicle and membrane. The melting point of a permeant is highly dependent upon its intra-crystalline
hydrogen bonding, confirming the importance of hydrogen bonding ability of the permeant, as well as
the hydrogen-bonding interactions between vehicle and membrane. Therefore, to achieve penetration,
a drug should have a low molecular weight (MW < 500 Da), moderate lipophilicity (Log p values
1–3), a low melting point ≤200 and few hydrogen binding points, and should be soluble in a vehicle,
which has a good solvation match with the barrier membrane. Therefore, in order to induce the
greatest interaction between the membrane and vehicle, the vehicle solvent should have similar partial
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HSP components to those of the membrane, and this can be evaluated by the HSP distance value
being small.
5. Conclusions
These results show that the use of synthetic membranes to determine the flux of permeants from oils
across epidermis should be treated with care. The diffusion results show that the vehicles containing the
highest molecular branching tended to promote the permeability of the model compounds. The highest
flux values for all model permeants were obtained when the compounds were suspended in IHD,
and all models (PCA and QSPR) showed the importance of the steric properties of the oily vehicle
on the permeation and flux of the small molecules. The diffusion of model permeants through the
membranes was also correlated with the uptake of what are typically considered to be non-interacting
oily vehicles into the different membranes. However, whether branched oils do interact more efficiently
with these membranes does require further validation with a wider range of oily vehicles.
The PCA analysis showed that descriptors of the oily vehicle dominated both solvent uptake
and permeant Kp. Similarly, the PCA assessment for flux using synthetic membranes identified the
physicochemical properties of the vehicle as having the most influence on the rate of flux. However,
the same observation was not true for the PCA assessment of flux carried out using human epidermis,
where both properties of the permeant and the oily vehicle were shown to be vital to explaining
the variance observed in the dataset. The QSPR models showed that it was possible to quantify
the variations in permeation and flux across synthetic membranes, using simple physicochemical
descriptor-based models, and once again highlighted the impact that of the properties of the oily
vehicle on flux and permeation.
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